位置:成果数据库 > 期刊 > 期刊详情页
基于CD4分子构型设计的小分子免疫抑制药J2抗移植排斥反应的作用研究
  • ISSN号:1004-0781
  • 期刊名称:《医药导报》
  • 时间:0
  • 分类:R979.5[医药卫生—药品;医药卫生—药学] R965[医药卫生—药理学;医药卫生—药学]
  • 作者机构:[1]解放军总医院眼科,北京100853
  • 相关基金:国家自然科学基金资助项目(基金编号:30471855)
中文摘要:

目的探讨小分子免疫抑制药J2抑制小鼠皮肤移植排斥反应的作用。方法以C57BL/6小鼠为供体、Balb/c小鼠为受体建立皮肤移植模型,将模型小鼠随机分为A组、B组、c组,每组15只,并分别给予空白液、环孢素A(10mg·kg^-1)和J2(30mg·kg^-1)灌胃,均每天给药1次,连续12d,比较各组皮瓣的存活时间和存活率,术后14d进行组织学检查。结果A组发生排斥反应的时间延迟,皮瓣平均存活时间为(13.7±1.4)d;B组皮瓣平均存活时间[(18,2±2,1)d]与C组皮瓣平均存活时间[(17,7±2.4)d]均较A组明显延长(均P〈0.05)。B组与C组平均皮瓣存活时间、存活率均差异无显著性(均P〉0.05)。组织学检查证实,C组术后14d植片未见明显淋巴细胞浸润。结论J2可明显抑制小鼠皮肤移植排斥反应。

英文摘要:

Objective To study the effect of a small - molecule compound J2 in the inhibition of skin allograft rejection in mice. Methods C57BL/6 and Balb/c mice were used as donors and recipients respectively for the establishment of a skin allagraft model. 45 mice with the model were then randomly divided into 3 equal groups. Mice of group A, B and C were given each placebo, 10 mg· kg^-1 of cyclosporin A and 30 mg·kg^-1 of J2 administered by gastrogavage q. d. , respectively. The course of treatment in the 3 groups lasted 12 days beginning at the day of transplantation. The graft survival time in mice of the different groups was assessed with the Kaplan-Meier analysis. 14 days after the transplantation, histological examination of the skin graft was carried out. Results The average graft survival time in mice of allograft control (group A) was ( 13.7 ± 1.4) d. The average graft survival tomes in mice of group B treated with cyclosporin A and mice of group C treated with J2 were ( 18.2 ± 2.1 ) d and (17.7 ±2.4) d, respectively, both of which being significantly longer than that of group A (P 〈0.01 ). The difference between the average graft survival times in mice of group B and C, however, was insignificant (P〉0.05 ). Histological examination demonstrated that no apparent lymphocyte infiltration could be found in the skin graft of mice treated with J2 (group C). Conclusion These results show that J2 can inhibit allograft rejection dramatically.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《医药导报》
  • 北大核心期刊(2011版)
  • 主管单位:湖北省食品药品监督管理局
  • 主办单位:中国药理学会、华中科技大学同济医学院附属同济医院
  • 主编:杜光
  • 地址:武汉市解放大道1095号
  • 邮编:430030
  • 邮箱:yydbzz@163.com
  • 电话:027-83663559 83643083 83666619
  • 国际标准刊号:ISSN:1004-0781
  • 国内统一刊号:ISSN:42-1293/R
  • 邮发代号:38-173
  • 获奖情况:
  • 2005年、2007年获湖北省优秀医学期刊奖,2010年获湖北省医学优秀精品期刊奖,2011年获湖北省医学优秀精品期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),波兰哥白尼索引,美国乌利希期刊指南,中国中国科技核心期刊,中国北大核心期刊(2011版)
  • 被引量:33223